Hypercalcaemia is a recognised adverse effect of toremifene, and the manufacturers suggest that drugs such as the thiazides, which decrease
renal calcium excretion, may increase the risk of hypercalcaemia.
This warning is based on theoretical considerations, and their
clinical importance awaits confirmation.